NewLink Genetics

Home » NewLink Genetics

Secondary

NewLink Genetics

NewLink Genetics is a late-stage biopharmaceutical company focusing on discovering, developing and commercializing novel immuno-oncology product candidates to improve the lives of patients with cancer

Symbol

NLNK

Last Closing Price
$10.91

Shares
4,000,000

Anticipated Date
TBD

Underwriters
BofA Merrill Lynch, Stifel

To view the prospectus for NewLink Genetics, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253